• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞毒性T淋巴细胞抗原4和CD28在调节T细胞功能时可调节细胞表面脂筏的表达。

Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function.

作者信息

Martin M, Schneider H, Azouz A, Rudd C E

机构信息

Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

出版信息

J Exp Med. 2001 Dec 3;194(11):1675-81. doi: 10.1084/jem.194.11.1675.

DOI:10.1084/jem.194.11.1675
PMID:11733581
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2193535/
Abstract

Coreceptors CD28 and cytotoxic T lymphocyte antigen (CTLA)-4 have opposing effects on TcR/CD3 activation of T cells. While CD28 enhances and CTLA-4 inhibits activation, the underlying molecular basis of these effects has yet to be established. In this context, ganglioside and cholesterol enriched membrane microdomains (rafts, GEMs) serve as centers of signaling in T cells. Although CD28 can promote TcR/raft colocalization, evidence is lacking on whether the surface expression of membrane rafts can be targeted by CTLA-4 in its modulation of T cell responses. In this study, we demonstrate that both CD28 and CTLA-4 profoundly alter the surface expression of membrane rafts during T cell activation. While CD28 increased expression and the number of peripheral T cells induced to express surface rafts in response to TcR ligation, CTLA-4 potently inhibited both TcR and TcR x CD28 induced raft expression on the surface of T cells. Consistent with this, CD28 increased the presence of the linker of activated T cells (LAT) in purified membrane rafts, while CTLA-4 coligation effectively blocked this increase. Further, the reversal of the CTLA-4 block with CD3/CD28 ligation was accompanied by an increase in surface raft expression and associated LAT. Our observations demonstrate for the first time that CTLA-4 targets the release of rafts to the surface of T cells, and provides a mechanism for the opposing effects of CD28 and CTLA-4 on costimulation.

摘要

共受体CD28和细胞毒性T淋巴细胞抗原(CTLA)-4对T细胞的TcR/CD3激活具有相反的作用。虽然CD28增强激活而CTLA-4抑制激活,但这些作用的潜在分子基础尚未明确。在此背景下,富含神经节苷脂和胆固醇的膜微结构域(脂筏,GEMs)作为T细胞信号传导的中心。尽管CD28可促进TcR/脂筏共定位,但缺乏关于CTLA-4在调节T细胞反应时是否可靶向膜脂筏表面表达的证据。在本研究中,我们证明CD28和CTLA-4在T细胞激活过程中均会深刻改变膜脂筏的表面表达。CD28增加了外周T细胞的表达以及响应TcR连接而诱导表达表面脂筏的细胞数量,而CTLA-4则强烈抑制TcR和TcR×CD28诱导的T细胞表面脂筏表达。与此一致的是,CD28增加了纯化膜脂筏中活化T细胞连接蛋白(LAT)的存在,而CTLA-4共连接有效地阻断了这种增加。此外,用CD3/CD28连接逆转CTLA-4阻断伴随着表面脂筏表达和相关LAT的增加。我们的观察首次证明CTLA-4靶向脂筏向T细胞表面的释放,并为CD28和CTLA-4在共刺激方面的相反作用提供了一种机制。

相似文献

1
Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function.细胞毒性T淋巴细胞抗原4和CD28在调节T细胞功能时可调节细胞表面脂筏的表达。
J Exp Med. 2001 Dec 3;194(11):1675-81. doi: 10.1084/jem.194.11.1675.
2
Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4.细胞毒性T淋巴细胞相关抗原4对T细胞受体-脂筏相互作用的负调控
J Exp Med. 2003 Jan 6;197(1):129-35. doi: 10.1084/jem.20021646.
3
Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation.表面细胞毒性T淋巴细胞相关抗原4在脂筏内分布,并在T细胞活化受抑制的条件下重新定位至免疫突触。
J Exp Med. 2002 May 20;195(10):1337-47. doi: 10.1084/jem.20011868.
4
Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.共刺激分子CD80和CD86及其受体CD28、CTLA-4在卵巢癌及其他类型腹膜癌患者恶性腹水中CD3⁺肿瘤浸润淋巴细胞(TIL)上的表达。
Clin Exp Immunol. 2000 Jan;119(1):19-27. doi: 10.1046/j.1365-2249.2000.01105.x.
5
Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2.细胞毒性T淋巴细胞相关抗原-4以及T细胞受体ζ链/CD3复合物,而非CD28,与网格蛋白衔接复合物AP-1和AP-2相互作用。
J Immunol. 1999 Aug 15;163(4):1868-79.
6
CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases.细胞毒性T淋巴细胞相关抗原4(CTLA-4)通过抑制ζ链相关蛋白激酶70(ZAP-70)酪氨酸(Tyr)319位点的磷酸化来抑制静息人CD4(+) T细胞中的近端T细胞受体(TCR)信号传导:酪氨酸磷酸酶的潜在作用
J Immunol. 2002 May 1;168(9):4420-9. doi: 10.4049/jimmunol.168.9.4420.
7
Cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibits CD28-induced IkappaBalpha degradation and RelA activation.细胞毒性T淋巴细胞抗原4(CTLA-4)抑制CD28诱导的IκBα降解和RelA激活。
Eur J Immunol. 1999 Mar;29(3):856-63. doi: 10.1002/(SICI)1521-4141(199903)29:03<856::AID-IMMU856>3.0.CO;2-P.
8
The flotillins are integral membrane proteins in lipid rafts that contain TCR-associated signaling components: implications for T-cell activation.小窝蛋白是脂筏中的整合膜蛋白,其包含与T细胞受体相关的信号成分:对T细胞活化的影响。
Clin Immunol. 2003 Aug;108(2):138-51. doi: 10.1016/s1521-6616(03)00097-4.
9
CTLA-4 ligation suppresses CD28-induced NF-kappaB and AP-1 activity in mouse T cell blasts.细胞毒性T淋巴细胞相关抗原4(CTLA-4)的连接抑制小鼠T细胞母细胞中CD28诱导的核因子κB(NF-κB)和激活蛋白1(AP-1)活性。
J Biol Chem. 1999 May 14;274(20):14400-5. doi: 10.1074/jbc.274.20.14400.
10
Non-CD28 costimulatory molecules present in T cell rafts induce T cell costimulation by enhancing the association of TCR with rafts.存在于T细胞筏中的非CD28共刺激分子通过增强T细胞受体与筏的结合来诱导T细胞共刺激。
J Immunol. 2000 Feb 1;164(3):1251-9. doi: 10.4049/jimmunol.164.3.1251.

引用本文的文献

1
CD4/CD8-p56 Induced T-Cell Receptor Signaling and Its Implications for Immunotherapy.CD4/CD8-p56诱导的T细胞受体信号传导及其对免疫治疗的意义。
Biomolecules. 2025 Jul 29;15(8):1096. doi: 10.3390/biom15081096.
2
Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy.抗 CTLA-4 纳米抗体作为癌症免疫治疗的一种有前途的方法。
Cell Death Dis. 2024 Jan 8;15(1):17. doi: 10.1038/s41419-023-06391-x.
3
Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer.肺癌中免疫检查点治疗方面的配置

本文引用的文献

1
Organization of plasma membrane functional rafts upon T cell activation.T细胞激活后质膜功能筏的组织
Eur J Immunol. 2001 Feb;31(2):345-9. doi: 10.1002/1521-4141(200102)31:2&#60;345::aid-immu345&#62;3.0.co;2-l.
2
The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A.CD28和CTLA-4受体与丝氨酸/苏氨酸磷酸酶PP2A相关联。
Immunity. 2000 Sep;13(3):313-22. doi: 10.1016/s1074-7613(00)00031-5.
3
Cell type specific localization of sphingomyelin biosynthesis.鞘磷脂生物合成的细胞类型特异性定位。
Cancers (Basel). 2023 Jan 16;15(2):543. doi: 10.3390/cancers15020543.
4
The efficacy and safety of immunotherapy in thymic epithelial tumors: more effective, more risky: a systematic review.免疫疗法在胸腺上皮肿瘤中的疗效与安全性:效果更佳,风险更高:一项系统综述
J Thorac Dis. 2021 Aug;13(8):5093-5103. doi: 10.21037/jtd-21-290.
5
Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpoint.靶向人酰基辅酶 A:胆固醇酰基转移酶作为双重病毒和 T 细胞代谢检查点。
Nat Commun. 2021 May 14;12(1):2814. doi: 10.1038/s41467-021-22967-7.
6
How the Discovery of the CD4/CD8-p56 Complexes Changed Immunology and Immunotherapy.CD4/CD8-p56复合物的发现如何改变了免疫学和免疫疗法。
Front Cell Dev Biol. 2021 Mar 15;9:626095. doi: 10.3389/fcell.2021.626095. eCollection 2021.
7
A sensitive S-Trap-based approach to the analysis of T cell lipid raft proteome.基于敏感 S 型陷阱的方法分析 T 细胞脂筏蛋白质组。
J Lipid Res. 2020 Nov;61(11):1512-1523. doi: 10.1194/jlr.D120000672. Epub 2020 Aug 7.
8
Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders.用于治疗自身免疫性疾病的抗CD28拮抗剂疗法。
Antibodies (Basel). 2017 Nov 21;6(4):19. doi: 10.3390/antib6040019.
9
CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy.CTLA-4 和 PD-1 对 T 细胞迁移和运动的控制:对肿瘤免疫治疗的影响。
Front Immunol. 2018 Nov 27;9:2737. doi: 10.3389/fimmu.2018.02737. eCollection 2018.
10
Influence of T Cell Coinhibitory Molecules on CD8 Recall Responses.T 细胞共抑制分子对 CD8 记忆应答的影响。
Front Immunol. 2018 Aug 8;9:1810. doi: 10.3389/fimmu.2018.01810. eCollection 2018.
FEBS Lett. 2000 Jul 28;478(1-2):9-12. doi: 10.1016/s0014-5793(00)01818-4.
4
GRID: a novel Grb-2-related adapter protein that interacts with the activated T cell costimulatory receptor CD28.GRID:一种与Grb-2相关的新型衔接蛋白,可与活化的T细胞共刺激受体CD28相互作用。
J Immunol. 2000 Jun 1;164(11):5805-14. doi: 10.4049/jimmunol.164.11.5805.
5
Adapter proteins in lymphocyte antigen-receptor signaling.淋巴细胞抗原受体信号传导中的衔接蛋白。
Curr Opin Immunol. 2000 Jun;12(3):256-66. doi: 10.1016/s0952-7915(00)00085-6.
6
The role of membrane-associated adaptors in T cell receptor signalling.膜相关衔接蛋白在T细胞受体信号传导中的作用。
Semin Immunol. 2000 Feb;12(1):35-41. doi: 10.1006/smim.2000.0205.
7
Tyrosine phosphatase SHP-2 binding to CTLA-4: absence of direct YVKM/YFIP motif recognition.酪氨酸磷酸酶SHP-2与CTLA-4的结合:不存在对YVKM/YFIP基序的直接识别
Biochem Biophys Res Commun. 2000 Mar 5;269(1):279-83. doi: 10.1006/bbrc.2000.2234.
8
Localization of LAT in glycolipid-enriched microdomains is required for T cell activation.LAT定位于富含糖脂的微结构域是T细胞激活所必需的。
J Biol Chem. 1999 Oct 8;274(41):28861-4. doi: 10.1074/jbc.274.41.28861.
9
Costimulatory regulation of T cell function.T细胞功能的共刺激调节
Curr Opin Cell Biol. 1999 Apr;11(2):203-10. doi: 10.1016/s0955-0674(99)80027-1.
10
Adaptors and molecular scaffolds in immune cell signaling.免疫细胞信号传导中的衔接蛋白和分子支架
Cell. 1999 Jan 8;96(1):5-8. doi: 10.1016/s0092-8674(00)80953-8.